Rothschild Investment LLC’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$739K Buy
10,972
+10,063
+1,107% +$670K 0.03% 492
2026
Q1
$57.1K Sell
909
-155
-15% -$10.8K ﹤0.01% 1077
2025
Q4
$70.6K Buy
1,064
+410
+63% +$26.5K ﹤0.01% 927
2025
Q3
$44K Buy
654
+245
+60% +$19.4K ﹤0.01% 1026
2025
Q2
$35.7K Sell
409
-300
-42% -$23.5K ﹤0.01% 866
2025
Q1
$48.4K Sell
709
-41
-5% -$3.35K ﹤0.01% 772
2024
Q4
$58.3K Buy
750
+536
+250% +$39.7K ﹤0.01% 751
2024
Q3
$14.3K Sell
214
-476
-69% -$39.1K ﹤0.01% 1073
2024
Q2
$78.2K Buy
690
+148
+27% +$18.7K 0.01% 675
2024
Q1
$75.2K Buy
542
+69
+15% +$8.67K 0.01% 652
2023
Q4
$58.7K Buy
+473
New +$48.3K ﹤0.01% 637

Other funds holding DXCM

Rothschild Investment LLC's DXCM Position: Q2 2026 in Review

Rothschild Investment LLC increased its DexCom (DXCM) stake by 1,107% in Q2 2026, buying an estimated $670K and bringing the position to 10,972 shares worth $739K. The position accounts for 0.03% of the portfolio, ranked #492.

Rothschild Investment LLC first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. 463 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Rothschild Investment LLC held 10,972 shares of DexCom worth $739K as of Q2 2026.
  • Rothschild Investment LLC bought 10,063 DexCom shares in Q2 2026, an estimated $670K.
  • DexCom made up 0.03% of Rothschild Investment LLC's portfolio in Q2 2026, its #492 holding.
  • Rothschild Investment LLC first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • 463 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.